METHOD FOR CORRECTING CARBOHYDRATE METABOLISM AND DECREASING BODY MASS IN METABOLIC SYNDROME

摘要

A method for correcting carbohydrate metabolism and decreasing the body mass in metabolic syndrome (MS) provides for examining the patients, diagnosing MS and administering the drugs that normalize carbohydrate metabolism. MS is diagnosed according to the criteria of the International Diabetes Federation (IDF, 2005) as modified in 2009 by the American Heart Association (AHA) and National Heart, Lung and Blood Institute (NHLBI). The patients with MS and impaired carbohydrate metabolism (fasting glycemia or 100 mg/dL) or previously diagnosed diabetes mellitus type 2 and/or abdominal obesity (waistline in males and in females), the inhibitors of sodium-glucose cotransporter-2 (Dapagliflozin, Canaglyflozin) are prescribed once a day at a dose of 10-20 mg on an individual basis.